Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- IMbrave151
A clinical trial to compare bevacizumab and atezolizumab, cisplatin and gemcitabine with atezolizumab, cisplatin and gemcitabine in people with untreated biliary tract cancer
A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
Cancer Biliary Tract Cancer
- Results
-
Download -
Study results
LPS GO42661 IMbrave151 Final Results May 2024 English
(PDF, 1.0 MB)
LPS GO42661 IMbrave151 Final Results May 2024 Italy Italian
(PDF, 0.7 MB)
LPS GO42661 IMbrave151 Final Results May 2024 Poland Polish
(PDF, 1.1 MB)
LPS GO42661 IMbrave151 Final Results May 2024 Spain Spanish
(PDF, 0.2 MB)
LPS GO42661 IMbrave151 Final Results May 2024 China Chinese
(PDF, 1.3 MB)
LPS GO42661 IMbrave151 Final Results May 2024 Hong Kong Chinese
(PDF, 1.6 MB)
LPS GO42661 IMbrave151 Final Results May 2024 Korea Korean
(PDF, 0.8 MB)
LPS GO42661 IMbrave151 Final Results May 2024 Taiwan Chinese
(PDF, 1.4 MB)
LPS GO42661 IMbrave151 Final Results May 2024 Thailand Thai
(PDF, 0.6 MB)
LPS GO42661 IMbrave151 Final Results May 2024 Russia Russian
(PDF, 1.3 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com